Northwestern Mutual Wealth Management’s Legend Biotech LEGN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$163	Buy	+9	New	+$172	﹤0.01%	3959

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northwestern Mutual Wealth Management's LEGN Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Legend Biotech (LEGN) in Q1 2026: 9 shares worth $163. The stake represents ﹤0.01% of the portfolio and ranks #3959 among its holdings.

190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Northwestern Mutual Wealth Management held 9 shares of Legend Biotech worth $163 as of Q1 2026.
Legend Biotech was a new Northwestern Mutual Wealth Management position in Q1 2026.
Legend Biotech made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3959 holding.
190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.